Synchron IPO

Synchron has developed an endovascular brain computer interface that can access every corner of the brain using its natural highways, the blood vessels. Their breakthrough platform launches a new frontier for the treatment of neurological diseases: Neurointerventional Electrophysiology (Neuro EP). This company was founded in 2016 and is headquartered in Brooklyn, NY.

Register for Details

For more details on financing and valuation for Synchron, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Synchron's ticker symbol?

Synchron does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

What is Synchron's stock price?

The stock price for Synchron will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Who are Synchron's major investors?

Khosla Ventures
Alumni Ventures
Bezos Expeditions
Green Sands Equity
General Advance

Synchron Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
12/15/2022 Series C and C-1 $400.53MM $XXX.XX $XXX.XX
6/3/2021 Series B and B-1 $139.83MM $XXX.XX $XXX.XX
4/4/2017 Series A $14.16MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about Synchron

Forge green plus iconForge green minus icon

What is Synchron funding to date?

Synchron has raised $118.41MM with the following series:
$14.16MM for Series A, $139.83MM for Series B and B-1, $400.53MM for Series C and C-1, $14.16MM for Series A, $139.83MM for Series B and B-1, $400.53MM for Series C and C-1.
Forge green plus iconForge green minus icon

When was Synchron founded?

Synchron was founded in 2016.
Forge green plus iconForge green minus icon

Can you invest in Synchron?

Synchron is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Synchron share pre-IPO?

If you own Synchron pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Synchron a publicly traded company?

Synchron is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Other companies like Synchron in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
 
 
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$298.33MM